what are the glp 1 drugs to Make of GLP-1 Coverage and Cost Landscape GLP-1 Drugs for Weight Loss:

In the GLORY-1 trial, the most frequently reported adverse events were gastrointestinal and mostly mild to moderate in severity

Emerging research shows they may help decrease neuroinflammation, particularly in diseases like Alzheimers and Parkinsons

In 2020, FDA granted fast track designation to efocipegtrutide for the treatment of nonalcoholic steatohepatitis (NASH), the most severe form of NAFLD

Diabetes Care 31 (12), 23152317

Thus, exenatide treated patients maintained their cognitive benefit 12-months following drug cessation, however, it should be noted that cognitive scores also remained unchanged for controls between 12 and 24 months